LEXINGTON, Mass., Oct. 11, 2016 /PRNewswire/ — TEPHA Inc, the pioneer developer of implantable medical devices based on a resorbable polymer known as poly4hydroxybutyrate (P4HB), announced today that the Company has completed a buy-out of its royalty obligation to its former licensor and parent company, Metabolix, Inc.  Beginning in 2008, Tepha and its partners have commercialized implantable medical […]